Effect of particle size, air flow and inhaler device on the aerosolisation of disodium cromoglycate powders

Recently, the dispersion of mannitol powders has demonstrated the importance of particle size, air flow and inhaler device ( Chew and Chan, 1999). The aim of the present study is to extend our investigation to a different compound, disodium cromoglycate (DSCG) powders. Solid state characteristics of...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:International journal of pharmaceutics 2000-09, Vol.206 (1), p.75-83
Hauptverfasser: Chew, Nora Y.K, Bagster, David F, Chan, Hak-Kim
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 83
container_issue 1
container_start_page 75
container_title International journal of pharmaceutics
container_volume 206
creator Chew, Nora Y.K
Bagster, David F
Chan, Hak-Kim
description Recently, the dispersion of mannitol powders has demonstrated the importance of particle size, air flow and inhaler device ( Chew and Chan, 1999). The aim of the present study is to extend our investigation to a different compound, disodium cromoglycate (DSCG) powders. Solid state characteristics of the powders were assessed by particle sizing, scanning electron microscopy, X-ray powder diffraction, moisture content, particle density determination and freeze fracture. The aerosol behaviour of the powders was studied by dispersion using Rotahaler® and Dinkihaler®, connected to a four-stage liquid impinger operating at 30–120 l/min. Three amorphous powders with a mass median diameter (MMD) of 2.3, 3.7, 5.2 μm and a similar polydispersity were prepared. The particles were nearly spherical with a particle density of 1.6 g/cm 3 and moisture content of 6.6 wt.%. Using Rotahaler®, the maximum fine particle fraction (FPF max) for all three powders was only 15 wt.%, attained at the highest flow of 120 l/min. Using Dinkihaler®, the FPF max was two to four times higher, being 36 and 29 wt.% for the 2.3 and 3.7 μm powder, respectively, at 60 l/min; and 18 wt.% for the 5.2 μm powder at 120 l/min. Hence, the study shows that the FPF in the DSCG powder aerosols was determined by the interaction of the particle size, air flow and inhaler design. The attribution of the amorphous nature and the different physico-chemical properties of the powder may explain the incomplete and low dispersibility of DSCG.
doi_str_mv 10.1016/S0378-5173(00)00516-0
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_72383554</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0378517300005160</els_id><sourcerecordid>72383554</sourcerecordid><originalsourceid>FETCH-LOGICAL-c456t-e770cf64a669f258e6ae37cf69045fedaf8736795a8861892e9597befc9ebc4e3</originalsourceid><addsrcrecordid>eNqFkUtrFTEUgIMo9rb6E5QsRCo4ejKZPGYlpVQtFFyo65CbnNhoZnJN5ra0v96092KXXR04fOf1HUJeMfjAgMmP34Er3Qmm-DHAOwDBZAdPyIppxTs-KPmUrP4jB-Sw1t8AIHvGn5MDxkBozfoV-XMWArqF5kA3tizRJaQ13uJ7amOhIeVramdP43xpExbq8So6pHmmyyVSiyXXnGK1S2yp1sPHmn3cTtSVPOVf6cbZBekmX3ss9QV5Fmyq-HIfj8jPz2c_Tr92F9--nJ-eXHRuEHLpUClwQQ5WyjH0QqO0yFXLjDCIgN6GdqJUo7BaS6bHHkcxqjUGN-LaDciPyNtd303Jf7dYFzPF6jAlO2PeVqN6rrkQQwPFDmzb1lowmE2Jky03hoG5s2zuLZs7hQbA3Fs20Ope7wds1xP6h6q91ga82QO2OptCsbOL9YETMPZCNOzTDsNm4ypiMdVFnB36WNpTjM_xkU3-AX0Amkw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>72383554</pqid></control><display><type>article</type><title>Effect of particle size, air flow and inhaler device on the aerosolisation of disodium cromoglycate powders</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Chew, Nora Y.K ; Bagster, David F ; Chan, Hak-Kim</creator><creatorcontrib>Chew, Nora Y.K ; Bagster, David F ; Chan, Hak-Kim</creatorcontrib><description>Recently, the dispersion of mannitol powders has demonstrated the importance of particle size, air flow and inhaler device ( Chew and Chan, 1999). The aim of the present study is to extend our investigation to a different compound, disodium cromoglycate (DSCG) powders. Solid state characteristics of the powders were assessed by particle sizing, scanning electron microscopy, X-ray powder diffraction, moisture content, particle density determination and freeze fracture. The aerosol behaviour of the powders was studied by dispersion using Rotahaler® and Dinkihaler®, connected to a four-stage liquid impinger operating at 30–120 l/min. Three amorphous powders with a mass median diameter (MMD) of 2.3, 3.7, 5.2 μm and a similar polydispersity were prepared. The particles were nearly spherical with a particle density of 1.6 g/cm 3 and moisture content of 6.6 wt.%. Using Rotahaler®, the maximum fine particle fraction (FPF max) for all three powders was only 15 wt.%, attained at the highest flow of 120 l/min. Using Dinkihaler®, the FPF max was two to four times higher, being 36 and 29 wt.% for the 2.3 and 3.7 μm powder, respectively, at 60 l/min; and 18 wt.% for the 5.2 μm powder at 120 l/min. Hence, the study shows that the FPF in the DSCG powder aerosols was determined by the interaction of the particle size, air flow and inhaler design. The attribution of the amorphous nature and the different physico-chemical properties of the powder may explain the incomplete and low dispersibility of DSCG.</description><identifier>ISSN: 0378-5173</identifier><identifier>EISSN: 1873-3476</identifier><identifier>DOI: 10.1016/S0378-5173(00)00516-0</identifier><identifier>PMID: 11058812</identifier><identifier>CODEN: IJPHDE</identifier><language>eng</language><publisher>Amsterdam: Elsevier B.V</publisher><subject>Aerosol inhaler ; Aerosols ; Air flow ; Amorphous powders ; Anti-Asthmatic Agents - chemistry ; Biological and medical sciences ; Cromolyn Sodium - chemistry ; Disodium cromoglycate ; General pharmacology ; Histamine and antagonists. Allergy ; Medical sciences ; Nebulizers and Vaporizers ; Particle Size ; Pharmaceutical technology. Pharmaceutical industry ; Pharmacology. Drug treatments ; Powders</subject><ispartof>International journal of pharmaceutics, 2000-09, Vol.206 (1), p.75-83</ispartof><rights>2000 Elsevier Science B.V.</rights><rights>2000 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c456t-e770cf64a669f258e6ae37cf69045fedaf8736795a8861892e9597befc9ebc4e3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0378517300005160$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=1509255$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/11058812$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Chew, Nora Y.K</creatorcontrib><creatorcontrib>Bagster, David F</creatorcontrib><creatorcontrib>Chan, Hak-Kim</creatorcontrib><title>Effect of particle size, air flow and inhaler device on the aerosolisation of disodium cromoglycate powders</title><title>International journal of pharmaceutics</title><addtitle>Int J Pharm</addtitle><description>Recently, the dispersion of mannitol powders has demonstrated the importance of particle size, air flow and inhaler device ( Chew and Chan, 1999). The aim of the present study is to extend our investigation to a different compound, disodium cromoglycate (DSCG) powders. Solid state characteristics of the powders were assessed by particle sizing, scanning electron microscopy, X-ray powder diffraction, moisture content, particle density determination and freeze fracture. The aerosol behaviour of the powders was studied by dispersion using Rotahaler® and Dinkihaler®, connected to a four-stage liquid impinger operating at 30–120 l/min. Three amorphous powders with a mass median diameter (MMD) of 2.3, 3.7, 5.2 μm and a similar polydispersity were prepared. The particles were nearly spherical with a particle density of 1.6 g/cm 3 and moisture content of 6.6 wt.%. Using Rotahaler®, the maximum fine particle fraction (FPF max) for all three powders was only 15 wt.%, attained at the highest flow of 120 l/min. Using Dinkihaler®, the FPF max was two to four times higher, being 36 and 29 wt.% for the 2.3 and 3.7 μm powder, respectively, at 60 l/min; and 18 wt.% for the 5.2 μm powder at 120 l/min. Hence, the study shows that the FPF in the DSCG powder aerosols was determined by the interaction of the particle size, air flow and inhaler design. The attribution of the amorphous nature and the different physico-chemical properties of the powder may explain the incomplete and low dispersibility of DSCG.</description><subject>Aerosol inhaler</subject><subject>Aerosols</subject><subject>Air flow</subject><subject>Amorphous powders</subject><subject>Anti-Asthmatic Agents - chemistry</subject><subject>Biological and medical sciences</subject><subject>Cromolyn Sodium - chemistry</subject><subject>Disodium cromoglycate</subject><subject>General pharmacology</subject><subject>Histamine and antagonists. Allergy</subject><subject>Medical sciences</subject><subject>Nebulizers and Vaporizers</subject><subject>Particle Size</subject><subject>Pharmaceutical technology. Pharmaceutical industry</subject><subject>Pharmacology. Drug treatments</subject><subject>Powders</subject><issn>0378-5173</issn><issn>1873-3476</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2000</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkUtrFTEUgIMo9rb6E5QsRCo4ejKZPGYlpVQtFFyo65CbnNhoZnJN5ra0v96092KXXR04fOf1HUJeMfjAgMmP34Er3Qmm-DHAOwDBZAdPyIppxTs-KPmUrP4jB-Sw1t8AIHvGn5MDxkBozfoV-XMWArqF5kA3tizRJaQ13uJ7amOhIeVramdP43xpExbq8So6pHmmyyVSiyXXnGK1S2yp1sPHmn3cTtSVPOVf6cbZBekmX3ss9QV5Fmyq-HIfj8jPz2c_Tr92F9--nJ-eXHRuEHLpUClwQQ5WyjH0QqO0yFXLjDCIgN6GdqJUo7BaS6bHHkcxqjUGN-LaDciPyNtd303Jf7dYFzPF6jAlO2PeVqN6rrkQQwPFDmzb1lowmE2Jky03hoG5s2zuLZs7hQbA3Fs20Ope7wds1xP6h6q91ga82QO2OptCsbOL9YETMPZCNOzTDsNm4ypiMdVFnB36WNpTjM_xkU3-AX0Amkw</recordid><startdate>20000925</startdate><enddate>20000925</enddate><creator>Chew, Nora Y.K</creator><creator>Bagster, David F</creator><creator>Chan, Hak-Kim</creator><general>Elsevier B.V</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20000925</creationdate><title>Effect of particle size, air flow and inhaler device on the aerosolisation of disodium cromoglycate powders</title><author>Chew, Nora Y.K ; Bagster, David F ; Chan, Hak-Kim</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c456t-e770cf64a669f258e6ae37cf69045fedaf8736795a8861892e9597befc9ebc4e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2000</creationdate><topic>Aerosol inhaler</topic><topic>Aerosols</topic><topic>Air flow</topic><topic>Amorphous powders</topic><topic>Anti-Asthmatic Agents - chemistry</topic><topic>Biological and medical sciences</topic><topic>Cromolyn Sodium - chemistry</topic><topic>Disodium cromoglycate</topic><topic>General pharmacology</topic><topic>Histamine and antagonists. Allergy</topic><topic>Medical sciences</topic><topic>Nebulizers and Vaporizers</topic><topic>Particle Size</topic><topic>Pharmaceutical technology. Pharmaceutical industry</topic><topic>Pharmacology. Drug treatments</topic><topic>Powders</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Chew, Nora Y.K</creatorcontrib><creatorcontrib>Bagster, David F</creatorcontrib><creatorcontrib>Chan, Hak-Kim</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>International journal of pharmaceutics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Chew, Nora Y.K</au><au>Bagster, David F</au><au>Chan, Hak-Kim</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Effect of particle size, air flow and inhaler device on the aerosolisation of disodium cromoglycate powders</atitle><jtitle>International journal of pharmaceutics</jtitle><addtitle>Int J Pharm</addtitle><date>2000-09-25</date><risdate>2000</risdate><volume>206</volume><issue>1</issue><spage>75</spage><epage>83</epage><pages>75-83</pages><issn>0378-5173</issn><eissn>1873-3476</eissn><coden>IJPHDE</coden><abstract>Recently, the dispersion of mannitol powders has demonstrated the importance of particle size, air flow and inhaler device ( Chew and Chan, 1999). The aim of the present study is to extend our investigation to a different compound, disodium cromoglycate (DSCG) powders. Solid state characteristics of the powders were assessed by particle sizing, scanning electron microscopy, X-ray powder diffraction, moisture content, particle density determination and freeze fracture. The aerosol behaviour of the powders was studied by dispersion using Rotahaler® and Dinkihaler®, connected to a four-stage liquid impinger operating at 30–120 l/min. Three amorphous powders with a mass median diameter (MMD) of 2.3, 3.7, 5.2 μm and a similar polydispersity were prepared. The particles were nearly spherical with a particle density of 1.6 g/cm 3 and moisture content of 6.6 wt.%. Using Rotahaler®, the maximum fine particle fraction (FPF max) for all three powders was only 15 wt.%, attained at the highest flow of 120 l/min. Using Dinkihaler®, the FPF max was two to four times higher, being 36 and 29 wt.% for the 2.3 and 3.7 μm powder, respectively, at 60 l/min; and 18 wt.% for the 5.2 μm powder at 120 l/min. Hence, the study shows that the FPF in the DSCG powder aerosols was determined by the interaction of the particle size, air flow and inhaler design. The attribution of the amorphous nature and the different physico-chemical properties of the powder may explain the incomplete and low dispersibility of DSCG.</abstract><cop>Amsterdam</cop><pub>Elsevier B.V</pub><pmid>11058812</pmid><doi>10.1016/S0378-5173(00)00516-0</doi><tpages>9</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0378-5173
ispartof International journal of pharmaceutics, 2000-09, Vol.206 (1), p.75-83
issn 0378-5173
1873-3476
language eng
recordid cdi_proquest_miscellaneous_72383554
source MEDLINE; Elsevier ScienceDirect Journals
subjects Aerosol inhaler
Aerosols
Air flow
Amorphous powders
Anti-Asthmatic Agents - chemistry
Biological and medical sciences
Cromolyn Sodium - chemistry
Disodium cromoglycate
General pharmacology
Histamine and antagonists. Allergy
Medical sciences
Nebulizers and Vaporizers
Particle Size
Pharmaceutical technology. Pharmaceutical industry
Pharmacology. Drug treatments
Powders
title Effect of particle size, air flow and inhaler device on the aerosolisation of disodium cromoglycate powders
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-02T01%3A33%3A29IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Effect%20of%20particle%20size,%20air%20flow%20and%20inhaler%20device%20on%20the%20aerosolisation%20of%20disodium%20cromoglycate%20powders&rft.jtitle=International%20journal%20of%20pharmaceutics&rft.au=Chew,%20Nora%20Y.K&rft.date=2000-09-25&rft.volume=206&rft.issue=1&rft.spage=75&rft.epage=83&rft.pages=75-83&rft.issn=0378-5173&rft.eissn=1873-3476&rft.coden=IJPHDE&rft_id=info:doi/10.1016/S0378-5173(00)00516-0&rft_dat=%3Cproquest_cross%3E72383554%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=72383554&rft_id=info:pmid/11058812&rft_els_id=S0378517300005160&rfr_iscdi=true